Active-ingredient Dossier
Cobicistat
Active-ingredient Dossier for Cobicistat (pharmacokinetic booster). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: EVOTAZ
- Brand: PREZCOBIX
- Brand: GENVOYA
- Brand: STRIBILD
- Brand: SYMTUZA
- Therapeutic area: Infectious Disease
What is
Cobicistat Cobicistat is a pharmacokinetic booster . It is used in combination antiretroviral therapy for the treatment of human immunodeficiency virus infection.
Australian brands containing
Cobicistat — SYMTUZA — GENVOYA — PREZCOBIX — EVOTAZ — STRIBILD
Therapeutic areas
Cobicistat is registered in the therapeutic area of Infectious Disease, with 5 brands containing this ingredient on the ARTG.
Sponsor landscape
Three sponsors market cobicistat in Australia: Gilead Sciences, Janssen-Cilag, and Bristol-Myers Squibb.
PBS and regulatory activity
Four brands containing cobicistat have PBAC outcomes on record, with the latest outcome dated 1 November 2019. Two brands have AusPARs on record, with the latest AusPAR dated 12 January 2016.